Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Head and Neck Cancer During Surgical Procedures

Grant

Date/time Interval

  • November 1, 2015 - October 31, 2020
  • Awarded By

    Total Award Amount

  • 0.00
  • Direct Costs

  • 0.00
  • Sponsor Award Id

  • Contributor

  • Anthony Morlandt D.D.S., M.D.   Investigator  
  • Benjamin Greene   Investigator  
  • Garima Agarwal   Investigator  
  • Jason Warram   Investigator  
  • Kirk Withrow   Investigator  
  • Lisle Nabell M.D.   Investigator  
  • Todd Stevens   Investigator  
  • William Carroll M.D.   Principal Investigator